Tribune Therapeutics has raised EUR 37M in Seed and Series A funding. The financing round was led by LifeArc Ventures and will be used to advance therapies targeting fibrotic diseases.
Amount Raised
€37 Million
Round Type
Seed
StockholmBiotechnologyHealth CareTherapeuticsInvestors
Description
Tribune Therapeutics AB, a biotechnology company based in Stockholm and Oslo, raised EUR 37M in seed and Series A funding. The round includes EUR 23M for Series A, led by LifeArc Ventures with participation from several investors. The funds will help advance a portfolio of therapies for fibrotic diseases, focusing on the lead program TRX-44 which is aimed at treating idiopathic pulmonary fibrosis. New board members from LifeArc and Industrifonden will join as part of this funding.
Quick answer
Tribune Therapeutics raised €37 Million in a Seed round, dated March 26, 2025. Investors: Healthcap, LifeArc Ventures, Inven2, Novo Holdings, Industrifonden, Investinor and Innovestor's Life Science Fund. Tribune Therapeutics is based in Stockholm, Stockholm County, Sweden.
- How much did Tribune Therapeutics raise?
- Tribune Therapeutics raised €37 Million in a Seed round on March 26, 2025.
- Who invested in Tribune Therapeutics?
- Healthcap, LifeArc Ventures, Inven2, Novo Holdings, Industrifonden, Investinor and Innovestor's Life Science Fund are named as investors in this round.
- What does Tribune Therapeutics do?
- Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.
- Where is Tribune Therapeutics based and how big is it?
- Tribune Therapeutics is based in Stockholm, Stockholm County, Sweden. Fundz records about 10 employees.
- Who are the decision-makers at Tribune Therapeutics?
- Fundz holds 1 contact at Tribune Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Tribune Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Cellestial Health raised an undisclosed amount (Pre-Seed) on May 9, 2025.
- ImmuneWalk Therapeutics raised $7M (Seed) on May 8, 2025.
- PAQ Therapeutics raised $39M (Series B) on May 7, 2025.
- Avammune Therapeutics raised $12M (Series A) on May 7, 2025.
- Paradigm Therapeutics raised $13M (Funding Round) on May 6, 2025.
- Azora Therapeutics, Inc. (DE) raised $4.8M on May 2, 2025.
Who to call at Tribune Therapeutics, and when
A new round usually means Tribune Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Tribune Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tribune Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tribune Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tribune Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Tribune Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.